RSS und Atom Feed Reader Online

Journal for Clinical Studies

Your resource for Multisite Studies

Talking Point with PCI Pharma Services

PCI Pharma Services is a trusted partner for globally integrated CDMO services. Can you tell our readers the brief history of your company, how the company got started and your growth so far? Established in 1971 and trading as Packaging Coordinators Inc. (PCI), the company provided contract packaging solutions to the pharmaceutical industry. Over the […]

The post Talking Point with PCI Pharma Services appeared first on Journal for Clinical Studies.

Veröffentlicht am 12.08.2022 um 15:22:43 Uhr - Kategorie: Current features - Autor: Mark Barker

The Importance of Conducting Diverse US Trials for US Cancer Patients

Since the early 1990s, overall cancer death rates have declined for most cancers in the US. According to the Annual Report to the Nation on the Status of Cancer – issued in March 2020 as part of a joint effort between the American Cancer Society (ACS), the Centers for Disease Control and Prevention (CDC), the […]

The post The Importance of Conducting Diverse US Trials for US Cancer Patients appeared first on Journal for Clinical Studies.

Veröffentlicht am 12.08.2022 um 15:13:53 Uhr - Kategorie: Current features - Autor: Mark Barker

An Open Letter of Appreciation to Clincial Trial Participants, Patient Advisors, Caregivers and HealthCare Professionals

Thank you! Those of us who have dedicated our careers to medical and health sciences share a mission to improve the lives of people everywhere through the development of innovative vaccines and medicines. We recognise that to be our very best for patients, we cannot do it alone. We want to express our sincere appreciation […]

The post An Open Letter of Appreciation to Clincial Trial Participants, Patient Advisors, Caregivers and HealthCare Professionals appeared first on Journal for Clinical Studies.

Veröffentlicht am 12.08.2022 um 15:08:38 Uhr - Kategorie: Current features - Autor: Mark Barker

Early Adoption of an Integrated Product Development Strategy will Reap Dividends

With both the cost and time to bring a drug to market ballooning, the importance of an integrated product development (IPD) strategy is gaining traction. This multidisciplinary approach to drug development brings key stakeholders together, breaking down barriers to an efficient and cost-effective path to market. But while more organisations are adopting an IPD strategy, […]

The post Early Adoption of an Integrated Product Development Strategy will Reap Dividends appeared first on Journal for Clinical Studies.

Veröffentlicht am 12.08.2022 um 14:59:35 Uhr - Kategorie: Current features - Autor: Mark Barker

Bridging the Gaps in the Analytical Procedure with Bayesian Statistics

The ICH-Q2 has stated that the objective of validation of an analytical procedure is to demonstrate that it is suitable for its intended purpose, yet it – as well as the ICH-Q14 – fails to clearly define the actual aim of the analytical procedure, leading to misunderstanding and confusion. Bruno Boulanger, Ph.D., Global Head Statistics […]

The post Bridging the Gaps in the Analytical Procedure with Bayesian Statistics appeared first on Journal for Clinical Studies.

Veröffentlicht am 12.08.2022 um 14:54:01 Uhr - Kategorie: Current features - Autor: Mark Barker

Understanding How Intellectual Property Insurance Can Protect Your Business

Intellectual property is an intangible business asset that often helps set companies apart from their competitors. Unfortunately, few businesses know precisely what their IP is worth, or how to protect it. Let’s step into the world of IP and explore the risks that you could be facing – and how you can build resilience for […]

The post Understanding How Intellectual Property Insurance Can Protect Your Business appeared first on Journal for Clinical Studies.

Veröffentlicht am 12.08.2022 um 14:46:23 Uhr - Kategorie: Current features - Autor: Mark Barker

Longitudinal Qualitative Research – Capturing the Patient Voice; Enhancing Patient Centricity

One of the best ways to ensure that a sponsor’s clinical and commercial programs reflect how patients experience a disease or a treatment is to interview patients directly over time. This practice – longitudinal qualitative research – is an emerging science that can guide development efforts as well as inform communication strategies for treatments in […]

The post Longitudinal Qualitative Research – Capturing the Patient Voice; Enhancing Patient Centricity appeared first on Journal for Clinical Studies.

Veröffentlicht am 12.08.2022 um 14:41:31 Uhr - Kategorie: Current features - Autor: Mark Barker

Clinical Trial Feasibility in a Changing World: Current Trends and Prospects

In recent years, there has been an upsurge in the number of (bio) pharmaceutical products under development globally, reaching an estimated 7,471 products in 2021, which represents a 2.3- fold increase compared to 2017 (Figure 1). This unprecedented expansion in the pipeline of innovative therapeutics and vaccines across a broad spectrum of diseases has in […]

The post Clinical Trial Feasibility in a Changing World: Current Trends and Prospects appeared first on Journal for Clinical Studies.

Veröffentlicht am 12.08.2022 um 14:32:19 Uhr - Kategorie: Current features - Autor: Mark Barker

Powerful Techniques Promoting Gene Therapy and Gene-mediated Cell Therapy Progress

Gene therapy and gene-mediated cell therapy (e.g. CAR-T cell therapy) approach hold great promise for treating debilitating diseases with unmet clinical needs. The drive to address the genetic cause of a disorder has brought about a gamut of innovative tools that can correct a cell’s function at the DNA level or engineer a cure via […]

The post Powerful Techniques Promoting Gene Therapy and Gene-mediated Cell Therapy Progress appeared first on Journal for Clinical Studies.

Veröffentlicht am 12.08.2022 um 14:20:53 Uhr - Kategorie: Current features - Autor: Mark Barker

Delivering on the Promise of Digital Trials: Simplified Experiences for Sites and Patients

The shift toward decentralised trials (DCTs) was not caused by COVID-19 but has certainly been accelerated by it. Research indicates that just 28% of sponsors and CROs ran DCTs before the pandemic.1 Now, 87% run DCTs, with estimates of an increase to 95% in years to come. DCTs should result in a more patient-centric experience. […]

The post Delivering on the Promise of Digital Trials: Simplified Experiences for Sites and Patients appeared first on Journal for Clinical Studies.

Veröffentlicht am 12.08.2022 um 14:11:52 Uhr - Kategorie: Current features - Autor: Mark Barker



Webhosting bei Alfahosting - jetzt kostenlos testen!